Amesite (AMST) investor relations material

Executive summary

• Completed strategic pivot from education-focused offerings to AI-powered healthcare solutions, primarily through the NurseMagic™ app, targeting both B2C and B2B markets.

• Achieved initial commercial traction with NurseMagic™, including HIPAA compliance and enterprise product launches, driving customer adoption.

• Maintained strong fiscal discipline, reducing operating expenses and cash burn while expanding the client base.

Financial highlights

• Net revenue for FY2025 was $110,459, down from $166,881 in FY2024, reflecting the transition to new markets.

• Net loss for FY2025 was approximately $3.62 million, an improvement from a $4.40 million net loss in FY2024.

• Operating expenses decreased to $3.71 million in FY2025 from $4.75 million in FY2024, driven by lower payroll and marketing costs.

• Cash balance as of June 30, 2025, was $2.43 million, bolstered by a $3.08 million public offering in January 2025.

• Recognized a $90,869 impairment loss due to discontinued development of the higher ed/professional learning app.

Outlook and guidance

• Management expresses substantial doubt about the ability to continue as a going concern due to ongoing losses and insufficient cash to fund operations for the next twelve months.

• Plans to generate cash through additional financing transactions, though success is uncertain and subject to market conditions.